Data from the TNBC subset of the prospective Nurses' Health Studies cohorts (n = 581) have reported, over a median follow up of 16.5 years, a significantly unfavorable breast cancer-specific survival in multivariable models for AR+ vs. AR- patients (8). The gene discussed is AR; the disease is breast carcinoma.